The clinical and characteristic features of the studied groups

Characteristic features/clinicopathological parametersMalignant (N = 50)Benign (N = 50)Control (N = 50)P value
No(%)Mean ± SENo(%)Mean ± SENo(%)Mean ± SE
Age
< 40816%50.6 ± 1.53366%33.9 ± 1.92142%40.8 ± 0.930.076
40–603468%1530%2958%
> 60816%24%00
Menstrual phase (in present)
Premenopausal2958%4896%3366%
Postmenopausal2142%24%1734%
Marital status
Married3468%2958%3264%
Single1020%2040%1734%
Divorced36%12%12%
Widowed36%0000%
Lactation history
Lactating3468%2754%2448%
Non-lactating1632%2346%2652%
Family history of BC
Yes714%612%510%
No4386%4488%4590%
Benign types
Fibro adenoma3978%
Others1122%
Side of complained
Right breast2244%2754%
Left breast2856%1734%
Both sides00612%
Cancer types
Invasive ductal carcinoma4794%
Lobular carcinoma36%
Cancer metastasis
Yes2142%
No2958%
LN involvement
Yes3774%
No1326%
Grade
Grade I612%
Grade II3162%
Grade III1122%
Grade IV24%
Mass
Yes4896%4182%
No24%918%
Discharge
Yes24%48%
No4896%4692%
Immunohistochemistry (IHC)
Estrogen receptors (ER)3570%
Progesterone receptors (PR)2856%
Human epidermal growth factor receptor-2 (Her2)1428%

BC: breast cancer; SE: standard error